Internalization of Rituximab and the Efficiency of B Cell Depletion in Rheumatoid Arthritis and Systemic Lupus Erythematosus

Publisher： John Wiley & Sons Inc

E-ISSN： 2326-5205|67|8|2046-2055

ISSN： 2326-5191

Source： ARTHRITIS & RHEUMATOLOGY, Vol.67, Iss.8, 2015-05, pp. : 2046-2055

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serum rituximab levels and efficiency of B cell depletion: differences between patients with rheumatoid arthritis and systemic lupus erythematosus

By Reddy Venkat  

British Journal of Rheumatology , Vol. 52, Iss. 5, 2013-05 ,pp. : 951-952

Oxford University Press

Access to resources Recommend Favorite

Association of FCGR3A and FCGR3B Copy Number Variations With Systemic Lupus Erythematosus and Rheumatoid Arthritis in Taiwanese Patients

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 11, 2014-11 ,pp. : 3113-3121

John Wiley & Sons Inc

Access to resources Recommend Favorite

Brief Report: Responses to Rituximab Suggest B Cell–Independent Inflammation in Cutaneous Systemic Lupus Erythematosus

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 6, 2015-06 ,pp. : 1586-1591

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rituximab in Systemic Lupus Erythematosus and Lupus Nephritis

By  

Nephron Clin Pract, Vol. 128, Iss. 3-4, 2015-0 ,pp. : 250-254

Karger

Access to resources Recommend Favorite

Current role of rituximab in systemic lupus erythematosus

By  

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 18, Iss. 2, 2015-02 ,pp. : 154-163

John Wiley & Sons Inc

Access to resources Recommend Favorite